Claims
- 1. A surface active composition comprising 20-95% phosphatides, said phosphatides comprising an unhydrolyzed phosphatidylcholine-enriched fraction and a hydrolyzed phosphatidylethanolamine-enriched fraction said unhydrolyzed phosphatidycholine-enriched fraction comprising diacyl-phosphatidylcholine (DPC) and lysophosphatidylcholine (LPC), and said hydrolyzed phosphatidylethanolamine fraction comprising diacyl-phosphatidylethanolamine (DPE) and at least 3% lysophosphatidylethanolamine (LPE), by weight of the phosphatides, wherein the ratio of the degree of hydrolysis of the phosphatidylethanolamine-enriched fraction to the degree of hydrolysis of the phosphatidylethanolamine-enriched fraction expressed as LPE/LPE+DPE:LPC/LPC+DPC is higher than 1.7.
- 2. Composition according to claim 1, wherein the hydrolysis ratio is 2-40.
- 3. Composition according to claim 1, wherein the total amount of diacylphosphatidylcholine (DPC) and lysophosphatidylethanolamine (LPE) in the composition is at least 40% by weight of the phosphatides.
- 4. Composition according to claim 3, wherein the total amount of diacylphosphatidylcholine (DPC) and lysophosphatidylethanolamine (LPE) is 50-80% by weight of the phosphatides.
- 5. Composition according to claim 1, wherein the total amount of diacylphosphatidylethanolamine (DPC) and lysophosphatidylcholine (LPE) is at most 30% by weight of the phosphatides.
- 6. Composition according to claim 5, wherein the total amount of diacylphosphatidylethanolamine (DPE) and lysophosphatidylcholine (LPC) is 2-20% by weight of the phosphatides.
- 7. Composition according to claim 1 wherein the overall degree of hydrolysis of the phosphatides is such that the phosphatides comprise 5-40% of lysophosphatides (LPE+LPC) by weight of the phosphatides.
- 8. Composition according to claim 1, wherein the composition comprises 40-90% phosphatides.
- 9. The composition of claim 1 wherein the total amount of lyosphosphatidylcholine (LPC) is 0-15%.
- 10. Process for preparing a surface-active composition according to claim 1 by fractionating a composition comprising phosphatides to yield a fraction enriched in phosphatidylcholine and a fraction enriched in phosphatidylethanolamine, hydrolysing the fraction enriched in phosphatidylethanolamine and combining the phosphatidylcholine-enriched fraction with the hydrolysed phosphatidylethanolamine-enriched fraction.
- 11. Process according to claim 10 wherein the step of fractionating is carried out by extracting with a solvent the composition comprising the phosphatides.
- 12. Process according to claim 11, wherein the solvent comprises alkanol having 1-3 carbon atoms.
- 13. Process according to claim 10, wherein the fraction enriched in phosphatidylethanolamine is hydrolysed until the degree of hydrolysis of phosphatidylethanolamine is at least 0.4.
- 14. Process according to claim 13, wherein the degree of hydrolysis of phosphatidylethanolamine is at least 0.6.
- 15. Edible composition comprising a fat phase, from 0-90% by weight of an aqueous phase and 0.01-2 wt. % of the surface-active composition of claim 1.
- 16. Composition according to claim 15 comprising 0.05-0.5 wt. % phosphatides.
- 17. Composition according to claim 15 comprising 10-100 wt. % fat phase.
- 18. Composition according to claim 17 comprising 60-100 wt. % fat phase, said fat phase being a continuous fat phase.
- 19. Composition according to claim 18 comprising 75-90 wt. % continuous fat phase and 10-25 wt. % aqueous phase dispensed in said fat phase.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8616041 |
Jul 1986 |
GBX |
|
Parent Case Info
This is a continuation application of Ser. No. 068,689, filed June 30, 1987 now abandoned.
US Referenced Citations (2)
Foreign Referenced Citations (4)
Number |
Date |
Country |
0141442 |
May 1985 |
EPX |
1113241 |
May 1968 |
GBX |
1215868 |
Dec 1970 |
GBX |
1355967 |
Jun 1974 |
GBX |
Non-Patent Literature Citations (1)
Entry |
Derwent Abstract for FR 2,106,372 Jun. 1974. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
68689 |
Jun 1987 |
|